Archives of Pharmacal Research

Papers
(The H4-Index of Archives of Pharmacal Research is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
CD48-expressing non-small-cell lung cancer cells are susceptible to natural killer cell–mediated cytotoxicity151
Mouse models of nonalcoholic steatohepatitis and their application to new drug development128
Ginsenoside-Rg2 exerts anti-cancer effects through ROS-mediated AMPK activation associated mitochondrial damage and oxidation in MCF-7 cells94
Renal tubular PAR2 promotes interstitial fibrosis by increasing inflammatory responses and EMT process63
Amyloidogenic, neuroinflammatory and memory dysfunction effects of HIV-1 gp12061
Antibody drug conjugates as targeted cancer therapy: past development, present challenges and future opportunities51
Correction to: Recent advances in CRISPR technologies for genome editing48
Continuous TNF-α exposure in mammary epithelial cells promotes cancer phenotype acquisition via EGFR/TNFR2 activation47
Osteogenic effect of an adiponectin-derived short peptide that rebalances bone remodeling: a potential disease-modifying approach for postmenopausal osteoporosis therapy47
Correction to: The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer46
Antibody-drug conjugates in cancer therapy: innovations, challenges, and future directions45
Anti-fibrotic effect of aurocyanide, the active metabolite of auranofin42
Donepezil improves skeletal muscle insulin resistance in obese mice via the AMPK/FGF21-mediated suppression of inflammation and ferroptosis42
Regulation of NOX/p38 MAPK/PPARα pathways and miR-155 expression by boswellic acids reduces hepatic injury in experimentally-induced alcoholic liver disease mouse model: novel mechanistic insight40
Advances in plant-derived natural products for antitumor immunotherapy39
Prenylated flavonoid fractions from Glycyrrhiza glabra alleviate insulin resistance in HepG2 cells by regulating the ERK/IRS-1 and PI3K/Akt signaling pathways35
Challenges and opportunities of developing small-molecule therapies for age-related macular degeneration35
Overexpressing microRNA-203 alleviates myocardial infarction via interacting with long non-coding RNA MIAT and mitochondrial coupling factor 633
Impact of binge drinking on alcoholic liver disease33
Retraction Note: Anti-inflammatory effect of atorvastatin on vascular reactivity and insulin resistance in fructose fed rats31
Myriocin suppresses tumor growth by modulating macrophage polarization and function through the PI3K/Akt/mTOR pathway30
Exosomal microRNAs as diagnostic and therapeutic biomarkers in non-malignant liver diseases30
The role and application of transcriptional repressors in cancer treatment29
Minor structural changes, major functional impacts: posttranslational modifications and drug targets28
A review on bacteria-derived antioxidant metabolites: their production, purification, characterization, potential applications, and limitations27
Recent advances on Pestalotiopsis genus: chemistry, biological activities, structure–activity relationship, and biosynthesis27
Naringin promotes fat browning mediated by UCP1 activation via the AMPK signaling pathway in 3T3-L1 adipocytes27
0.15956497192383